Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

Oncologist - United States
doi 10.1634/theoncologist.2012-0397
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?

Journal of Oncology
Oncology
2020English

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-Like Versus Non-Basal-Like Phenotypes

International Journal of Medical Sciences
Medicine
2018English

Triple-Negative (Basal-Like) Breast Cancer: A New Entity

Breast Cancer Research
Cancer ResearchOncology
2007English

Are Triple Negative Tumours and Basal-Like Breast Cancer Synonymous?

Breast Cancer Research
Cancer ResearchOncology
2007English

Triple-Negative Breast Cancer: Clinicopathological Characteristics and Relationship With Basal-Like Breast Cancer

Modern Pathology
Forensic MedicinePathology
2009English

Basal-Like Breast Cancer; Clinicopathological, Molecular, and Prognostic Features

Archives of Breast Cancer
2019English

Biomarkers for Basal-Like Breast Cancer

Cancers
Cancer ResearchOncology
2010English

SHP2 Acts Both Upstream and Downstream of Multiple Receptor Tyrosine Kinases to Promote Basal-Like and Triple-Negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2016English

Frequency and Distribution of Cytoplasmic and Nuclear P63 in Recognizing the Basal-Like and Non-Basal-Like Types of Breast Cancer Based on Age.

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy